Insider buying
~$42K9,519 sh @ $4.40
Traded May 21, 2025 · filed 1 day later
The CEO of Vanda Pharmaceuticals paid $42K out of pocket for Vanda Pharmaceuticals shares.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Jun 13, 2025 · Filed Jun 17, 2025
A Vanda Pharmaceuticals director sold $32K of Vanda Pharmaceuticals shares. The filing does not indicate a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$32,130
Shares × reported transaction price
37 days after results of May 7, 2025, 48 days before results of Jul 31, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
Insider buying
Traded May 21, 2025 · filed 1 day later
The CEO of Vanda Pharmaceuticals paid $42K out of pocket for Vanda Pharmaceuticals shares.
Insider buying
Traded May 21, 2025 · filed 1 day later
The CEO of Vanda Pharmaceuticals paid $2.1K out of pocket for Vanda Pharmaceuticals shares.
Insider buying
Traded May 16, 2025 · filed 3 days later
The CEO of Vanda Pharmaceuticals paid $84K out of pocket for Vanda Pharmaceuticals shares.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.